Abstract
Infrared spectroscopy and imaging technology can provide new diagnostic capabilities for cancer research applications and to physicians directly involved in patient treatment. A methodology that permits the phenotypical description of cells and tissues is introduced, as well as a variety of new evaluation techniques that allow researchers and physicians to evaluate the infrared data at different levels of sophistication. The detection of cell alterations in the case of Chronic Lymphocytic Leukemia (CLL) demonstrates the capability of infrared spectroscopy to identify and stage this type of cancer, providing new prospects for diagnosis and treatment. The pathological study of oral tissue affected by Squamous Cell Carcinoma (SCC) illustrates the potential of Infrared Spectroscopy and Imaging for tissue diagnosis and cancer staging based in altered cell biochemistry, without using stains or any other marker technology. An example of combined fluid, cell and tissue analysis of thyroid cancers based on infrared technology is introduced to demonstrate the possibility of earlier detection of gland abnormalities and biochemical alterations in cell extracts using fine needle aspirates. Simple statistical techniques such as bivariate histogram analysis can distinguish between normal and altered cells and tissues when applied to infrared spectra and images. More complex mathematical techniques such as Principal Component Analysis (PCA) or Artificial Neural Networks (ANN) provide additional evaluation capabilities that can relate spectra of an unknown sample to an infrared reference database of known cell states. It is documented how this new infrared technology could enhance the diagnoses, treatment decisions and prognoses of patients in the field of cancer medicine.